European Business Schools Librarian's Group

Department of Economics Working Papers,
Vienna University of Economics and Business, Department of Economics

No 343: Market Power and Regulation in Pharmaceutical Markets

Klaus Gugler () and Florian Szücs ()
Additional contact information
Klaus Gugler: Department of Economics, Vienna University of Economics and Business
Florian Szücs: Department of Economics, Vienna University of Economics and Business

Abstract: We exploit the regulatory environment in the Austrian pharmaceutical market to study the effects of price regulation on market outcomes and consumer welfare. We evaluate all mergers of drug producers in the 2009-2017 period and find that the coexisting regulated and unregulated markets were unequally affected. While M&A have substantially increased prices without regulation, particularly for price-inelastic products, prices did not increase under regulation. Instead, variety increased in regulated markets. Therefore, regulation can successfully mitigate the effects of market power: whereas M&A decrease consumer welfare absent regulation, the additional product variety increases consumer welfare in the regulated market.

Keywords: pharmaceuticals, regulation, market power, consumer welfare, pharma mergers, product variety

JEL-codes: L65; I18; D22; I11; L51; G34 July 2023

Note: PDF Document

Full text files

WP343.pdf PDF-file 

Download statistics

Report problems with accessing this service to Sune Karlsson ().

RePEc:wiw:wiwwuw:wuwp343This page generated on 2024-12-21 04:36:25.